De novo synthesis of purine nucleotides in human peripheral blood leukocytes. Excessive activity of the pathway in hypoxanthine-guanine phosphoribosyltransferase deficiency.
Open Access
- 1 August 1976
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 58 (2) , 289-297
- https://doi.org/10.1172/jci108471
Abstract
Human peripheral blood leukocytes were studied for the presence and the regulatory properties of the pathway of de novo synthesis of purine nucleotides. The cells were found to incorporate the labeled precursors formate and glycine into purines. The rate of [14C]-formate incorporation was decreased by several compounds known to inhibit purine synthesis by affecting the activity by glutamine phosphoribosylpyrophosphate (PRPP) amidotransferase, the first committed enzyme in the pathway, either through decreasing the availability of PRPP, a substrate for this enzyme, or through exerting inhibition on this enzyme. PRPP availability in the leukocyte was found to be limiting for purine synthesis. Increased PRPP availability resulting from activation of PRPP synthetase by increasing inorganic phosphate (Pi) concentration caused acceleration of purine synthesis. On the other hand, no clear-cut evidence was obtained for the availability of ribose-5-phosphate in the leukocyte being rate limiting at physiological extracellular Pi concentration for PRPP generation, and thus for purine synthesis. However, the addition of methylene blue, which accelerates the oxidative pentose shunt that produces ribose-5-phosphate, resulted in acceleration of PRPP generation and of purine synthesis only when PRPP synthetase was largely activated at high Pi concentration. These results may be taken to suggest that ribose-5-phosphate availability is indeed not limiting for PRPP generation under physiological conditions. Purine synthesis de novo was accelerated more than 13-fold in the leukocytes of two gouty patients affected with partial deficiency of hypoxanthine-guanine phosphoribosyltransferase, but was normal in the leukocytes of an obligate heterozygote for this enzyme abnormality. The results domonstrate in peripheral human leukocytes the presence of the complete pathway of de novo synthesis of purine nucleotides and the manifestation in these cells of the biochemical consequences of hypoxanthine-guanine phosphoribosyltransferase deficiency, i.e., increased availability of PRPP and acceleration of purine synthesis de novo. The results indicate the usefulness of leukocytes as a model tissue for the study of purine metabolism in man.This publication has 26 references indexed in Scilit:
- Multiple mechanisms of regulation of purine biosynthesis de novo in intact tumor cellsBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1974
- Electrophoretic characterization of human phosphoribosylpyrophosphate synthetaseBiochemical Medicine, 1974
- Kinetics of amidophosphoribosyltransferase in intact tumor cellsBiochimica et Biophysica Acta (BBA) - Enzymology, 1974
- Observations of Altered Intracellular Phosphoribosylpyrophosphate (PP-Ribose-P) in Human DiseasePublished by Springer Nature ,1974
- Characterization of a Feedback-Resistant Phosphoribosylpyrophosphate Synthetase from Cultured, Mutagenized Hepatoma Cells That Overproduce PurinesProceedings of the National Academy of Sciences, 1973
- Human glutamine phosphoribosylpyrophosphate amidotransferase. Kinetic and regulatory properties.1973
- Repression and Derepression of Purine Biosynthesis in Mammalian Hepatoma Cells in CultureJournal of Biological Chemistry, 1972
- Enzymatic Deficiencies of Purine Nucleotide Synthesis in the Human ErythrocyteJournal of Biological Chemistry, 1962
- HUMAN LEUKOCYTE METABOLISM IN VITRO. I. INCORPORATION OF ADENINE-8-C14 AND FORMATE-C14 INTO THE NUCLEIC ACIDS OF LEUKEMIC LEUKOCYTESJournal of Clinical Investigation, 1962
- BIOSYNTHESIS OF THE PURINES .15. THE EFFECT OF AZA-L-SERINE AND 6-DIAZO-5-OXO-L-NORLEUCINE ON INOSINIC ACID BIOSYNTHESIS DE NOVO1957